Jay Luly
Chief Executive Officer presso ENANTA PHARMACEUTICALS, INC.
Patrimonio netto: 14 M $ in data 31/03/2024
Profilo
Jay R.
Luly is the President, Chief Executive Officer & Director of Enanta Pharmaceuticals, Inc. He previously held positions as Director at Artesian Therapeutics, Inc., SVP-Drug Discovery & Pre-Clinical Development at Abbott Laboratories, Senior VP-Research & Development Operations at Millennium Pharmaceuticals, Inc., and Senior VP-Drug Discovery & Preclinical Development at LeukoSite, Inc. He also served as a Trustee at The Boston Biomedical Research Institute.
Luly holds a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Illinois.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 12/02/2024 | 810 609 ( 3.83% ) | 14 M $ | 31/03/2024 |
Posizioni attive di Jay Luly
| Società | Posizione | Inizio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Chief Executive Officer | 01/07/2003 |
Precedenti posizioni note di Jay Luly
| Società | Posizione | Fine |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| The Boston Biomedical Research Institute | Director/Board Member | - |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Director/Board Member | - |
Formazione di Jay Luly
| University of California, Berkeley | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
Artesian Therapeutics, Inc.
Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
| The Boston Biomedical Research Institute |
- Borsa valori
- Insiders
- Jay Luly
